LON:APH Alliance Pharma (APH) Share Price, News & Analysis GBX 37.25 +0.40 (+1.09%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range 35.90▼ 37.9550-Day Range 32.85▼ 41.9052-Week Range 24.55▼ 52.80Volume388,552 shsAverage Volume1.63 million shsMarket Capitalization£201.30 millionP/E RatioN/ADividend Yield5.37%Price TargetGBX 56.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider Trades Get Alliance Pharma alerts: Email Address Alliance Pharma MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside51.7% UpsideGBX 56.50 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.23 out of 5 stars 3.3 Analyst's Opinion Consensus RatingAlliance Pharma has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageAlliance Pharma has received no research coverage in the past 90 days.Read more about Alliance Pharma's stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for APH. Previous Next 1.7 Dividend Strength Dividend LeadershipAlliance Pharma is a leading dividend payer. It pays a dividend yield of 3.75%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthAlliance Pharma does not have a long track record of dividend growth.Read more about Alliance Pharma's dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for APH. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for Alliance Pharma this week, compared to 0 articles on an average week.Search InterestOnly 24 people have searched for APH on MarketBeat in the last 30 days. This is a decrease of -56% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Alliance Pharma to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Alliance Pharma insiders have not sold or bought any company stock.Percentage Held by Insiders11.76% of the stock of Alliance Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions68.25% of the stock of Alliance Pharma is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Alliance Pharma's insider trading history. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Alliance Pharma is -3,725.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Alliance Pharma is -3,725.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioAlliance Pharma has a PEG Ratio of 1.04. PEG Ratios around 1 indicate that a company is correctly valued.Price to Book Value per Share RatioAlliance Pharma has a P/B Ratio of 0.73. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Alliance Pharma Stock (LON:APH)Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics. It provides its products under the Aloclair, Anbesol, Asthon and Parsons, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. Alliance Pharma plc was incorporated in 1996 and is headquartered in Chippenham, the United Kingdom.Read More APH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart APH Stock News HeadlinesJuly 23, 2024 | msn.comAIM-listed Alliance Pharma axes chief operating officer roleMay 24, 2024 | sg.finance.yahoo.comAlliance Pharma PLC (DVL.SG)July 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.May 9, 2024 | msn.comAlliance Pharma delays results again and chief executive exitsMay 8, 2024 | msn.comIndian Pharmaceutical Alliance Calls for a Stronger U.S.-India Partnership for Affordable MedicineMay 1, 2024 | wsj.comAlliance Pharma PLCApril 17, 2024 | tmcnet.comAphaia Pharma to Participate in a Panel Discussion at the 10th LSX World CongressFebruary 5, 2024 | msn.comHealthcare firm Alliance Pharma appoints new chairJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.January 31, 2024 | lse.co.ukLONDON BROKER RATINGS: Jefferies raises Spirax-Sarco; cuts VictrexJanuary 15, 2024 | finance.yahoo.comInvestors in Alliance Pharma (LON:APH) have unfortunately lost 52% over the last three yearsNovember 30, 2023 | markets.businessinsider.comAscendis Pharma’s Growth Potential Bolstered by Strategic Partnership and Product PipelineNovember 23, 2023 | morningstar.comAlliance Pharma PLC APHNovember 11, 2023 | uk.investing.comAlliance Pharma (ALAPH)October 19, 2023 | finance.yahoo.comCalculating The Intrinsic Value Of Alliance Pharma plc (LON:APH)June 2, 2023 | fool.co.ukShould you invest in Mark Slater favourite Alliance Pharma right now?May 28, 2023 | msn.comNumis Reiterates Alliance Pharma (LSE:APH) Buy RecommendationMarch 24, 2023 | finance.yahoo.comEarnings Miss: Alliance Pharma plc Missed EPS By 95% And Analysts Are Revising Their ForecastsSee More Headlines Receive APH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alliance Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryElectronic Equipment Current SymbolLON:APH CUSIPN/A CIKN/A Webwww.alliancepharma.co.uk Phone+44-1249-466966FaxN/AEmployees91,000Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 56.50 High Stock Price TargetGBX 60 Low Stock Price TargetGBX 53 Potential Upside/Downside+51.7%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)GBX (0.01) Trailing P/E RatioN/A Forward P/E Ratio8.37 P/E Growth1.04Net Income£-7,060,000.00 Net Margins-4.15% Pretax MarginN/A Return on Equity-2.46% Return on Assets2.99% Debt Debt-to-Equity Ratio45.00 Current Ratio1.93 Quick Ratio1.42 Sales & Book Value Annual Sales£170.05 million Price / Sales1.18 Cash FlowGBX 4.73 per share Price / Cash Flow7.87 Book ValueGBX 51 per share Price / Book0.73Miscellaneous Outstanding Shares540,400,000Free FloatN/AMarket Cap£201.30 million OptionableNot Optionable Beta0.61 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Andrew Timothy Franklin (Age 58)CFO & Executive Director Comp: $271.52kMr. Peter Jonathan Butterfield (Age 48)Executive Officer Comp: $399.83kMr. Nick SedgwickChief Executive OfficerMr. Jeyan Heper (Hons) (Age 50)BA, COO & Director Mr. Stephen KidnerChief Scientific Affairs OfficerMs. Cora Maeve McCallum C.F.A.Head of Investor Relations & Corporate CommunicationsMr. Christodoulos Theoclis ChrysanthouGroup General Counsel & Company SecretaryMr. Alex DugganChief Commercial & Corporate Development OfficerJulie SkinnerChief People OfficerChris DelafieldGlobal Marketing Head of Kelo-CoteMore ExecutivesKey CompetitorsEmpiric Student PropertyLON:ESPInternational Personal FinanceLON:IPFMS INTERNATIONALLON:MSISigma Capital GroupLON:SGMMind GymLON:MINDView All CompetitorsInsidersAndrew FranklinSold 42,053 sharesTotal: £1.64 M ($39.00/share)View All Insider Transactions APH Stock Analysis - Frequently Asked Questions How have APH shares performed this year? Alliance Pharma's stock was trading at GBX 40.50 on January 1st, 2024. Since then, APH shares have decreased by 8.0% and is now trading at GBX 37.25. View the best growth stocks for 2024 here. How do I buy shares of Alliance Pharma? Shares of APH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of Alliance Pharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that Alliance Pharma investors own include RPC Group (RPC), American Airlines Group (AAL), BlackBerry (BB), Editas Medicine (EDIT), 1-800-FLOWERS.COM (FLWS), Air Canada (AC) and Ally Financial (ALLY). This page (LON:APH) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored4 Steps to Survive the Coming Market CrashCracks threaten us with a widespread collapse unlike anything we've seen in our lifetime. During this prese...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alliance Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Alliance Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
